槐耳颗粒联合肝动脉化疗栓塞术治疗不可切除肝癌临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R735.7

基金项目:


Clinical Study on Huai'er Granules Combined with Transarterial Chemoembolization for Unresectable Liver Cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察槐耳颗粒联合肝动脉化疗栓塞术(TACE) 治疗不可切除肝癌的临床疗效。方法:采用 便利抽样法将100 例不可切除肝癌患者分为对照组及研究组,每组50 例。2 组均开展TACE,研究组在TACE 治疗的同时给予槐耳颗粒口服。比较2 组临床治疗效果、不良反应发生率、中位肿瘤进展时间、血液指标[甲 胎蛋白(AFP)、谷丙转氨酶(ALT)、总胆红素(TBil)],以及随访半年、1 年生存率。结果:研究组、对照 组总有效率分别为52.00%、48.00%,2 组比较,差异无统计学意义(P>0.05)。治疗1 个月、3 个月,2 组 AFP、TBil 水平均较治疗前降低(P<0.05),ALT 水平均较治疗前升高(P<0.05);研究组AFP 水平低于同期 对照组(P<0.05),2 组ALT、TBil 水平比较,差异均无统计学意义(P>0.05)。研究组及对照组不良反应发 生率分别为50.00%、44.00%,2 组比较,差异无统计学意义(P>0.05)。研究组中位肿瘤进展时间(175.65± 10.37) d,长于对照组(129.52±20.43) d(P<0.05)。研究组半年、1 年生存率分别为70.00%、50.00%,与对 照组64.00%、44.00%比较,差异均无统计学意义(P>0.05)。结论:槐耳颗粒联合TACE 治疗不可切除肝癌 安全有效,可改善患者的肝功能,延长肿瘤进展时间。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Huai'er Granules combined with transarterial chemoembolization(TACE) for unresectable liver cancer. Methods: A total of 100 cases of patients with unresectable liver cancer were divided into the control group and the study group according to the convenience sampling method,with 50 cases in each group. Both groups received TACE,and the study group was additionally given the oral administration with Huai'er Granules. The clinical effects, the incidence of adverse reactions, median tumor progression time, blood indexes[alpha fetoprotein(AFP), alanine aminotransferase(ALT) and total bilirubin(TBil)],and the survival rates of half a year and one year of follow- up were compared between the two groups. Results:The total effective rate was 52.00% in the study group,compared with 48.00% in the control group,there being no significant difference(P>0.05). After one month and three months of treatment,the levels of AFP and TBil in both groups were decreased when compared with those before treatment(P<0.05), and the levels of ALT were increased(P<0.05); the AFP level in the study group was lower than that in the control group at the same period(P<0.05),there were no significant differences being found in the comparison of levels of ALT and TBil between the two groups(P>0.05). The incidence of adverse reactions was 50.00% in the study group and 44.00% in the control group,compared between the two groups,there being no significance in the difference(P>0.05). The median tumor progression time(175.65 ± 10.37)days in the study group was longer than that of (129.52±20.43) days in the control group(P<0.05). The survival rates of half a year and one year of followup were 70.00% and 64.00% in the study group,compared with 50.00% and 44.00% in the control group, there being no significant difference(P>0.05). Conclusion:Huai'er Granules combined with TACE treat for unresectable liver cancer is safe and effective,which can improve the liver function of patients,prolong the time of tumor progression and enhance the survival rates.

    参考文献
    相似文献
    引证文献
引用本文

吴建男,郑朝晖.槐耳颗粒联合肝动脉化疗栓塞术治疗不可切除肝癌临床研究[J].新中医,2022,54(24):149-152

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-01-01
  • 出版日期: